Careers  |  Sign In  |  Register
The Scope of the Problem – Understanding the Role of the PCP in HIV Management
Course List
  • CME Front Matter

Downloadable Education Resources

Sponsorship Statement

This continuing medical education activity is provided by Vindico Medical Education

Support Statement

This activity is supported by an educational grant from Gilead Medical Affairs

Target Audience

The intended audience for the activity is primary care physicians, nurse practitioners and other healthcare professionals involved in the treatment of patients with HIV.

Learning Objectives

At the conclusion of this activity participants should be able to:

  • Incorporate appropriate HIV screening techniques into practice according to evidence-based recommendations.
  • Utilize strategies that link patients with HIV to the appropriate care upon diagnosis.
  • Implement the use of Pre-Exposure Prophylaxis (PrEP) as recommended in individuals who are at-risk for HIV.


The Scope of the Problem – Understanding the Role of the PCP in HIV Management
Sally L. Hodder MD
Professor of Medicine
Director, HIV Programs, Department of Medicine
Rutgers, New Jersey Medical School
Newark, NJ

Key Elements of Screening and Education
Richard Elion, MD
Associate Clinical Professor of Medicine
George Washington University School of Medicine
Washington, DC

Patient Counseling and the Role of Pre-Exposure Prophylaxis
Cal Cohen, MD
Director of Research
Community Research Initiative (CRI)
Boston, MA


Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

This enduring material is approved for 1 year from the date of original release, May 30, 2014 to May 29, 2015.

How To Participate in this Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, read the articles, complete the CME posttest, and complete and return the registration form and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)TM Certificate.

Planning Committee and Faculty:

Cal Cohen, MD
Richard Elion, MD
Sally L. Hodder, MD


W. David Hardy, MD
Ronald A. Codario, MD, FACP, RPVI, FNLA, CCMEP


In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page and the next page

  • Planning Committee and Faculty members report the following relationship(s):

    • Cal Cohen, MD
      • Consulting Fee: Bristol Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co., Viiv Healthcare
      • Contracted Research: Bristol Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co., Viiv Healthcare
      • Expert Testimony: Gilead Sciences

    • Richard Elion, MD
      • Consulting Fee: Bristol Myers Squibb, Gilead, ViiV Healthcare
      • Speakers Bureau: Bristol Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co., ViiV Healthcare
      • Contracted Research: AbbVie, Bristol Myers Squibb, Gilead Sciences, Merck & Co., ViiV Healthcare

    • Sally L. Hodder, MD
      • Consulting Fee: Bristol Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co.
      • Contracted Research: Bristol Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, ViiV
      • Ownership Interest (Spouse): Merck & Co

  • Reviewers reports the following relationship(s):

    • W. David Hardy, MD
      • Consulting Fee: Bristol Myers Squibb, Boerhinger Ingelheim, Calimmune, Gilead Sciences, GlaxoSmithKine, Janssen Pharmaceuticals, ViiV Healthcare
      • Speakers’ Bureau: ViiV Healthcare
      • Fees for Non-CE Services Received Directly from a Commercial Interest or its Agent: ViiV Healthcare
      • Contracted Research: Bionor, Gilead, ViiV Healthcare, Vertex
      • Ownership Interest: Merck & Co. (<$5000)

    • Ronald A. Codario, MD, FACP, FNLA, CCMEP
      • No relevant financial relationships to disclose.
  • Vindico Medical Education staff report the following relationship(s):
    • No relevant financial relationships to disclose.
  • Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


A substantial proportion of Americans with HIV remain undiagnosed and suboptimally treated. Failure to follow recommended screening protocols, particular for high-risk individuals, results in delayed diagnosis. Once diagnosed, many patients are lost to care increasing the risk of HIV transmission. Despite a high level of awareness of the evidence for pre-exposure prophylaxis (PrEP) use, uptake by HIV health care providers is poor, especially for at-risk women, placing them at higher risk for infection. The disparity in HIV diagnosis and care has been attributed to a number of factors, including difficulty in accessing high-risk individuals and attitudes towards screening among primary health care providers. Similarly, PrEP is suboptimally implemented. In order to improve the rates of HIV detection, diagnosis and prophylaxis, it is necessary to address the barriers among primary care physicians. In this CME activity strategies to improve HIV diagnosis and implementation of the PrEP program in the primary care setting are discussed.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement (for use in Enduring Materials)

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2013 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at